Sun Mingwei,Lin Ru.Research advances of postoperative coagulation management during pediatric cardiac surgery[J].Journal of Clinical Pediatric Surgery,2021,20(06):550-556.[doi:10.12260/lcxewkzz.2021.06.009]
小儿先天性心脏病手术后出凝血管理的研究进展
- Title:
- Research advances of postoperative coagulation management during pediatric cardiac surgery
- Keywords:
- Heart Diseases/CN; Heart Defects; Congenital/SU; Postoperative Hemorrhage; Coagulation Management; Blood Transfusion; Child
- 分类号:
- R541;R459.51;R442.7
- 摘要:
- 出血与凝血功能障碍是先天性心脏病（以下简称先心病）手术后常见的并发症，严重者会影响患者预后，甚至直接或间接导致死亡。先心病手术后出凝血管理是围术期管理的重点和难点。手术后早期以旋转式血栓弹力监测（rotational thromboelastometry，ROTEM）算法为导向的出凝血管理在国外心脏手术病人中广泛应用，但国内尚无统一规范的出凝血管理流程，本文就小儿先心病手术后出凝血管理的研究进展进行综述。
- Abstract:
- Postoperative hemorrhage and coagulopathy are common complications of congenital heart disease (CHD).Both partially affect the prognosis and even directly or indirectly lead to death.Management of postoperative coagulation has been a troublesome focus of perioperative management.Early postoperative rotational thromboelastometry (ROTEM)-guided and algorithm-based coagulation management have been successfully applied during cardiac procedures in other countries.However,there is no standardized management protocol in China.This review summarized the latest advances.
参考文献/References:
1 任璐璐,沈立.微创手术治疗儿童先天性心脏病的应用进展[J].临床小儿外科杂志,2020,19(10):943-948.DOI:10.3969/j.issn.1671-6353.2020.10.016. Ren LL,Shen L.Recent advances of mini-invasive pediatric cardiac surgery[J].J Clin Ped Sur,2020,19(10):943-948.DOI:10.3969/j.issn.1671-6353.2020.10.016.
2 Gaies M,Pasquali SK,Donohue JE,et al.Seminal postoperative complications and mode of death after pediatric cardiac surgical procedures[J].Ann Thorac Surg,2016,102(2):628-635.DOI:10.1016/j.athoracsur.2016.02.043.
3 McCrindle BW,Li JS,Manlhiot C,et al.Challenges and priorities for research:a report from the National Heart,Lung,and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease[J].Circulation,2014,130(14):1192-1203.DOI:10.1161/ CIRCULATIONAHA.113.008428.
4 Lill MC,Perloff JK,Child JS.Pathogenesis of thrombocytopenia in cyanotic congenital heart disease[J].Am J Cardiol,2006,98(2):254-258.DOI:10.1016/j.amjcard.2006.01.083.
5 Laskine-Holland ML,Kahr WH,Crawford-Lean L,et al.The association between cyanosis and thromboelastometry (ROTEM) in children with congenital heart defects:a retrospective cohort study[J].Anesth Analg,2017,124(1):23-29.DOI:10.1213/ANE.0000000000001708.
6 Rizza A,Di Felice G,Luciano R,et al.Calibrated automated thrombogram values in infants with cardiac surgery before and after cardiopulmonary bypass[J].Thromb Res,2017,160:91-96.DOI:10.1016/j.thromres.2017.09.021.
7 Kremers RM,Wagenvoord RJ,de Laat HB,et al.Low pediatric thrombin generation is caused by an attenuation of prothrombin conversion[J].Thromb Haemost,2016,115(6):1090-1100.DOI:10.1160/TH15-09-0716.
8 奚爱华,罗雯懿,何萍萍.先天性心脏病术后异常出血的观察与护理[J].上海护理,2016,16(3):65-66. Xi AH,Luo WY,He PP.Observation and nursing of postoperative abnormal bleeding of congenital heart disease[J].Shanghai Nursing,2016,16(3):65-66.
9 刘宇航,文平,刘启龙,等.75例低龄低体重先心病急诊、亚急诊心内直视手术疗效分析[J].临床小儿外科杂志,2019,18(9):779-783.DOI:10.3969/j.issn.1671-6353.2019.09.015. Liu YH,Wen P,Liu QL,et al.Emergency and sub-emergency operations for congenital heart disease in 75 infants with a low age and a low body weight[J].J Clin Ped Sur,2019,18(9):779-783.DOI:10.3969/j.issn.1671-6353.2019.09.015.
10 Chidester SJ,Williams N,Wang W,et al.A pediatric massive transfusion protocol[J].J Trauma Acute Care Surg,2012,73(5):1273-1277.DOI:10.1097/TA.0b013e318265d267.
11 Poisson JL,Tuma CW,Shulman IA.Inventory management strategies that reduce the age of red blood cell components at the time of transfusion[J].Transfusion,2016,56(7):1758-1762.DOI:10.1111/trf.13639.
12 Peterson JA,Maroney SA,Zwifelhofer W,et al.Heparin-protamine balance after neonatal cardiopulmonary bypass surgery[J].J Thromb Haemost,2018,16(10):1973-1983.DOI:10.1111/jth.14245.
13 Boer C,Meesters MI,Veerhoek D,et al.Anticoagulant and side-effects of protamine in cardiac surgery:a narrative review[J].Br J Anaesth,2018,120(5):914-927.DOI:10.1016/j.bja.2018.01.023.
14 Koster A,Borgermann J,Gummert J,et al.Protamine overdose and its impact on coagulation,bleeding,and transfusions after cardiopulmonary bypass:results of a randomized double-blind controlled pilot study[J].Clin Appl Thromb Hemost,2014,20(3):290-295.DOI:10.1177/1076029613484085.
15 Peterson JA,Maroney SA,Zwifelhofer W,et al.Heparin-protamine balance after neonatal cardiopulmonary bypass surgery[J].J Thromb Haemost,2018,16(10):1973-1983.DOI:10.1111/jth.14245.
16 Spahn DR.TEG?-or ROTEM?-based individualized goal-directed coagulation algorithms:don’t wait-act now![J].Crit Care,2014,18(6):637.DOI:10.1186/s13054-014-0637-3.
17 Boer C,Meesters MI,Milojevic M,et al.2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery[J].J Cardiothorac Vasc Anesth,2018,32(1):88-120.DOI:10.1053/j.jvca.2017.06.026.
18 Kane LC,Woodward CS,Husain SA,et al.Thromboelastography-does it impact blood component transfusion in pediatric heart surgery?[J].J Surg Res,2016,200(1):21-27.DOI:10.1016/j.jss.2015.07.011.
19 Nakayama Y,Nakajima Y,Tanaka KA,et al.Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery[J].Br J Anaesth,2015,114(1):91-102.DOI:10.1093/bja/aeu339.
20 Chaiwat O,Lang JD,Vavilala MS,et al.Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma[J].Anesthesiology,2009,110(2):351-360.DOI:10.1097/ALN.0b013e3181948a97.
21 Ponschab M,Sch?chl H,Gabriel C,et al.Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells,platelet concentrate and four different plasma preparations[J].Anaesthesia,2015,70(5):528-536.DOI:10.1111/anae.13067.
22 Holcomb JB,del Junco DJ,Fox EE,et al.The prospective,observational,multicenter,major trauma transfusion (PROMMTT) study:comparative effectiveness of a time-varying treatment with competing risks[J].JAMA Surg,2013,148(2):127-136.DOI:10.1001/2013.jamasurg.387.
23 Holcomb JB,Tilley BC,Baraniuk S,et al.Transfusion of plasma,platelets,and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma:the PROPPR randomized clinical trial[J].JAMA,2015,313(5):471-482.DOI:10.1001/2013.jamasurg.387.
24 Fitzgerald J,Lenihan M,Callum J,et al.Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery:a propensity score matched comparison to plasma[J].Br J Anaesth,2018,120(5):928-934.DOI:10.1016/j.bja.2018.02.017.
25 Godier A,Greinacher A,Faraoni D,et al.Use of factor concentrates for the management of perioperative bleeding:guidance from the SSC of the ISTH[J].J Thromb Haemost,2018,16(1):170-174.DOI:10.1111/jth.13893.
26 Kozek-Langenecker SA,Ahmed AB,Afshari A,et al.Management of severe perioperative bleeding:guidelines from the European Society of Anaesthesiology:first update 2016[J].Eur J Anaesthesiol,2017,34(6):332-395.DOI:10.1111/jth.13893.
27 Spahn DR,Bouillon B,Cerny V,et al.The European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma:Fifth Edition[J].Crit Care,2019,23(1):98.DOI:10.1186/s13054-019-2347-3.
28 Sisti DJ,Williams GD,Ding V,et al.Prothrombin complex concentrates in pediatric cardiac surgery:the current state and the future[J].Ann Thorac Surg,2017,104(4):1423-1431.DOI:10.1016/j.athoracsur.2017.04.009.
29 Guzzetta NA,Russell IA,Williams GD.Review of the off-label use of recombinant activated factor VⅡ in pediatric cardiac surgery patients[J].Anesth Analg,2012,115(2):364-378.DOI:10.1213/ANE.0b013e31825aff10.
30 强生生物外科止血系列家族[J].中国医疗器械信息,2012,98(10):98. Johnson & Johnson biosurgical hemostasis serial family[J].China Medical Device Information,2012,98(10):98.
31 欧满灿,苏洁明,吴盾,等.鼻内镜术后不同填塞材料对患者术后出血、疼痛的影响[J].吉林医学,2019,40(1):143-144.DOI:10.3969/j.issn.1004-0412.2019.01.065. Ou MC,Su JM,Wu D,et al.Comparsion of two packing hemostatic materials after functional endoscopic sinus surgery[J].Jilin Medical Journal,2019,40(1):143-144.DOI:10.3969/j.issn.1004-0412.2019.01.065.
32 Myles PS,Smith JA,Painter T.Tranexamic acid in patients undergoing coronary-artery surgery[J].N Engl J Med,2017,376(19):1893.DOI:10.1056/NEJMoa1606424.
33 Shakur H,Roberts I,Fawole B,et al.Effect of early tranexamic acid administration on mortality,hysterectomy,and other morbidities in women with post-partum haemorrhage (WOMAN):an international,randomised,double-blind,placebo-controlled trial[J].Lancet,2017,389(10084):2105-2116.DOI:10.1016/S0140-6736(17)30638-4.
34 Cole E,Davenport R,Willett K,et al.Tranexamic acid use in severely injured civilian patients and the effects on outcomes:a prospective cohort study[J].Ann Surg,2015,261(2):390-394.DOI:10.1097/SLA.0000000000000717.
35 Giancarelli A,Birrer KL,Alban RF,et al.Hypocalcemia in trauma patients receiving massive transfusion[J].J Surg Res,2016,202(1):182-187.DOI:10.1016/j.jss.2015.12.036.
36 Paparella D,Parolari A,Rotunno C,et al.The effects of steroids on coagulation dysfunction induced by cardiopulmonary bypass:a Steroids in Cardiac Surgery (SIRS) trial substudy[J].Semin Thorac Cardiovasc Surg,2017,29(1):35-44.DOI:10.1053/j.semtcvs.2017.01.007.
37 Ferrer-Marin F,Stanworth S,Josephson C,et al.Distinct differences in platelet production and function between neonates and adults:implications for platelet transfusion practice[J].Transfusion,2013,53(11):2814-2821.DOI:10.1111/trf.12343.
38 Lin CY,Shuhaiber JH,Loyola H,et al.The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery[J].PLoS One,2015,10(5):e0126514.DOI:10.1371/journal.pone.0126514.
39 Manlhiot C,Gruenwald CE,Holtby HM,et al.Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children:impact of low antithrombin activity[J].J Thorac Cardiovasc Surg,2016,151(2):444-450.DOI:10.1016/j.jtcvs.2015.10.003.
40 Romlin BS,Soderlund F,Wahlander H,et al.Perioperative monitoring of platelet function in paediatric cardiac surgery by thromboelastometry,or platelet aggregometry?[J].Br J Anaesth,2016,116(6):822-828.DOI:10.1093/bja/aew053.
41 Forman KR,Diab Y,Wong EC,et al.Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia:a retrospective case-control study[J].BMC Pediatr,2014,14:277.DOI:10.1186/1471-2431-14-277.
42 Cholette JM,Faraoni D,Goobie SM,et al.Patient Blood Management in Pediatric Cardiac Surgery:A Review[J].Anesth Analg,2018,127(4):1002-1016.DOI:10.1213/ANE.0000000000002504.
43 Guzzetta NA,Miller BE,Todd K,et al.An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates[J].Anesth Analg,2005,100(5):1276-1282.DOI:10.1213/01.ANE.0000149590.59294.3A.
44 Gruenwald CE,Manlhiot C,Chan AK,et al.Randomized,controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass[J].J Am Coll Cardiol,2010,56(22):1794-1802.DOI:10.1016/j.jacc.2010.06.046.
45 Extracorporeal Life Support Organization (ELSO),ELSO Database Definitions 02-01-2018[EB/OL].https://www.elso.org/Portals/0/Files/PDF/ELSO%20Database%20Definitions%202018-2-1,2018-02-02.
46 Dalton HJ,Garcia-Filion P,Holubkov R,et al.Association of bleeding and thrombosis with outcome in extracorporeal life support[J].Pediatr Crit Care Med,2015,16(2):167-174.DOI:10.1097/PCC.0000000000000317.
47 Ando M,Takahashi Y,Suzuki N.Open heart surgery for small children without homologous blood transfusion by using remote pump head system[J].Ann Thorac Surg,2004,78(5):1717-1722.DOI:10.1016/j.athoracsur.2004.05.006.
48 Khorsandi M,Davidson M,Bouamra O,et al.Extracorporeal membrane oxygenation in pediatric cardiac surgery:A retrospective review of trends and outcomes in Scotland[J].Ann Pediatr Cardiol,2018,11(1):3-11.DOI:10.4103/apc.APC_88_17.
相似文献/References:
[1]张泽伟,齐建川,高展,等.改良Carpentier法治疗Ebstein畸形[J].临床小儿外科杂志,2010,9(06):404.
ZHANG Ze wei,QI Jian chuan,GAO Zhan,et al.Modified Carpentier’s repair technique in the treatment of Ebstein’s Anomaly: a Clinical Analysis of 18 Cases.[J].Journal of Clinical Pediatric Surgery,2010,9(06):404.
[2]柏松,李晓峰,袁峰,等.单源化手术治疗肺动脉闭锁合并室间隔缺损及重要主肺动脉侧支血管[J].临床小儿外科杂志,2010,9(06):410.
BAI Song,LI Xiao feng,YUAN Feng,et al.Unifocalization repair for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.[J].Journal of Clinical Pediatric Surgery,2010,9(06):410.
[3]常绘文,沈振亚.右腋下小切口在儿童心内手术中的应用[J].临床小儿外科杂志,2010,9(06):439.
[4]丁晋阳 莫绪明 顾海涛 孙剑 彭卫 戚继荣 沈立 束亚琴 钱龙宝. 延迟关胸技术在婴儿复杂危重先心病手术中的应用[J].临床小儿外科杂志,2011,10(02):98.
DING Jin yang,MO Xu ming,GU Hai tao,et al. Delayed Sternal Closure following operations for complex and severe congenital heart disease in infant[J].Journal of Clinical Pediatric Surgery,2011,10(06):98.
[5]麻晓鹏,王涛,祖莹,等.肺动脉平滑肌细胞钙含量与先心病肺动脉高压的关联性研究[J].临床小儿外科杂志,2008,7(01):9.
[6]陈纲,贾兵,陈张根,等.儿童复杂先天性心脏病肺动脉环缩术后二期手术时机的探讨[J].临床小儿外科杂志,2008,7(02):10.
[7]宁岩松,乔彬,王同建,等.小婴儿先天性心脏病术后的呼吸管理[J].临床小儿外科杂志,2008,7(04):0.
[8]袁捷,谷兴琳,姜子菲,等.婴儿先天性心脏病非择期手术81例[J].临床小儿外科杂志,2008,7(04):0.
[9]谢学良,明腾,邹勇,等.209例体重5kg以下婴儿先天性心脏病的外科治疗及围术期处理[J].临床小儿外科杂志,2008,7(06):3.
[10]范庆浩,郑雪梅,黄国金,等.婴幼儿先天性心脏病手术治疗47例[J].临床小儿外科杂志,2007,6(03):15.
[11]陈纲,关吏,陈伟呈,等.先天性心脏病产前产后诊治一体化管理初步经验[J].临床小儿外科杂志,2021,20(06):525.[doi:10.12260/lcxewkzz.2021.06.005]
Chen Gang,Guan Li,Chen Weicheng,et al.Preliminary management experience of integrated congenital heart disease diagnosis and treatment during perinatal period[J].Journal of Clinical Pediatric Surgery,2021,20(06):525.[doi:10.12260/lcxewkzz.2021.06.005]
[12]庞亚昌,徐卓明,张明杰,等.腹膜透析在小儿先天性心脏病手术后的应用[J].临床小儿外科杂志,2021,20(08):743.[doi:10.12260/lcxewkzz.2021.08.008]
Pang Yachang,Xu Zhuoming,Zhang Mingjie,et al.Application and effect of peritoneal dialysis in children after congenital heart surgery[J].Journal of Clinical Pediatric Surgery,2021,20(06):743.[doi:10.12260/lcxewkzz.2021.08.008]
备注/Memo
收稿日期:2020-10-29;。
通讯作者:林茹,Email:linru008@163.com